3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Urinary Bladder Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pinealoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Neuroendocrine Tumors
1
Myeloproliferative Disorders
1
Mammary Neoplasms, Animal
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Kidney Neoplasms
1
Hodgkin Disease
1
Fallopian Tube Neoplasms
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Interventions
Cyclophosphamide
13
Etoposide
10
Prednisone
8
Doxorubicin
8
Whole-Body Irradiation
7
Vincristine
7
Rituximab
7
Peripheral Blood Stem Cell Transplantation
7
Melphalan
7
Brentuximab Vedotin
7
romidepsin
6
fludarabine phosphate
6
Mycophenolic Acid
6
fludarabine
5
Lenalidomide
5
Gemcitabine
5
Cytarabine
5
10-propargyl-10-deazaaminopterin
5
Tacrolimus
4
Granulocyte Colony-Stimulating Factor
4
Carmustine
4
Busulfan
4
Antilymphocyte Serum
4
pembrolizumab
3
etoposide phosphate
3
carmustine, poliferprosan 20 drug combination
3
Vorinostat
3
Sirolimus
3
Nivolumab
3
Filgrastim
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, T-Cell
×
entinostat
×
Clear all
No trials found.